Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
10/2008
10/16/2008US20080255123 (2Z)-2-(3-butyl-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene)-1-(5-chloro-2-methoxyphenyl)ethanone; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants
10/16/2008US20080255108 Novel thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions
10/16/2008US20080255095 Benzylamine analogues
10/16/2008US20080255094 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
10/15/2008EP1979335A2 Thiazoles as 11 beta-hsd1 inhibitors
10/15/2008EP1979334A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
10/15/2008EP1979322A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
10/15/2008EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1567112B1 THIAZOLIDIN-4-ONES FOR INHIBITING hYAK3 PROTEINS
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1308436B1 Calcium receptor antagonists
10/15/2008EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/15/2008CN101287718A Substituted heteroaryl- and phenylsulfamoyl compounds
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN101284810A Cyano-pyrrolidine and cyano-tetrahydrothiazole derivates
10/15/2008CN100425600C Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as CDC25 phosphatase inhibitors
10/15/2008CN100425594C PPAR-activating compound and pharmaceutical composition comprising the compound
10/14/2008US7435828 immunosuppressive agents; low dosages; 5-[4-(2-hydroxy-ethoxy)-benz[Z]ylidene]-2-([Z]-isopropylimino)-3-o-tolyl-thiazolidin-4-one
10/14/2008US7435815 Sulfonylamino-acetic acid derivatives
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/09/2008WO2008121558A1 1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
10/09/2008WO2008120744A1 Five-membered cyclic amide compound and use thereof
10/09/2008WO2008119238A1 Substituted five membered heterocycle compounds, preparation method and medical use thereof
10/09/2008WO2008062276A8 Acetylene derivatives as stearoyl coa desaturase inhibitors
10/09/2008US20080249130 Oral dosage forms; antiproliferatives, anticholesterol agents; lipid metabolic disorders; myocardial infarction, stroke, restenosis, atherosclerosis
10/09/2008US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid
10/09/2008US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide
10/09/2008CA2681586A1 1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
10/08/2008EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/08/2008EP1976839A2 Compounds and methods for modulating protein trafficking
10/08/2008EP1976835A2 Histone deacetylase inhibitors
10/08/2008EP1697316B1 Novel intermediates for the synthesis of (r)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation
10/08/2008EP1660493B1 Peptidyl heterocyclic ketone derivatives and preparation processes
10/08/2008EP1606351A4 Cyanine dye labelling reagents with meso-substitution
10/08/2008CN101282957A 新的药物化合物 New pharmaceutical compounds
10/08/2008CN101282950A Novel benzothiazolone derivatives
10/08/2008CN101282949A Azole and thiazole derivatives and their use
10/08/2008CN101282937A Therapeutic agents
10/08/2008CN101282920A Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents
10/07/2008US7432392 Ester derivatives and medical use thereof
10/07/2008US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/07/2008US7432254 Method for treating glaucoma IC
10/07/2008US7431741 Brightening colorant with indolythiazolium dyes
10/02/2008WO2008118122A2 Compounds and amyloid probes thereof for therapeutic and imaging uses
10/02/2008WO2008020211A3 Benzimidazole, benzoxazole and benzothiazole derivatives, optical film comprising them and method of production thereof
10/02/2008US20080242869 Tri(Cyclo) Substituted Amide Compounds
10/02/2008US20080242868 Process for preparing epothilone derivatives by selective catalytic epoxidation
10/02/2008US20080242709 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
10/02/2008US20080242708 Fungicides/bactericides for plant protection; exhibit a strong fortifying effect in plants; for controlling cereal diseases against Puccinia species, and diseases in viticulture and fruit and vegetable production against Botrytis, Venturia or Alternaria species; low toxicity; tolrerance
10/02/2008US20080242671 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide
10/02/2008US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
10/02/2008US20080242654 Novel compounds as cannabinoid receptor ligands
10/02/2008CA2677991A1 Thiazolidine derivatives
10/01/2008EP1973890A2 Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
10/01/2008EP1973875A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
10/01/2008EP1973404A1 Malononitrile compounds
10/01/2008EP1496877B1 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
10/01/2008CN101277933A Substituted propylamine derivatives and methods of their use
10/01/2008CN101274920A Bis(2-benzothiazolydiazoamino)-biphenyl, preparation and application thereof
10/01/2008CN101274919A 1,8-bis(2-benzothiazolydiazoamino)- naphthaline, preparation and application thereof
10/01/2008CN101274918A Substitutive five membered heterocyclic compound, preparation and medical use thereof
10/01/2008CN100422185C Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
10/01/2008CN100422179C 2-amino-5-benzoylthiazole npy antagonists
10/01/2008CN100422163C Compound for preparing fluorescein and its preparation method
09/2008
09/30/2008US7429659 Isopropyl-piperazin-1-yl)-(5-piperidin-1-ylmethyl-furan-2-yl)-methanone; 5-(4-Fluoro-piperidin-1-ylmethyl)-furan-2-yl]-(4-isopropyl-piperazin-1-yl)-methanone, fumarate salt; insomnia, attention deficit hyperactivity disorders, learning disorders, cognitive dysfunction, eating disorders, obesity
09/30/2008US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists
09/30/2008US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/30/2008US7429278 N-(2-Thiophen-2-ylethyl)benzene-1,4-diamine; hair dye; very strong and sparingly selective coloration of keratin fibers, light fast, avoiding the degradation of the fibers
09/30/2008US7429274 Agent and method for the oxidative coloring of keratin fibers
09/30/2008CA2381001C Carbamate derivative and agricultural/horticultural fungicide
09/30/2008CA2355470C Benzoheterocycles and their use as mek inhibitors
09/25/2008WO2008115433A1 Desferrithiocin polyether analogues
09/25/2008WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
09/25/2008WO2008113760A2 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes
09/25/2008WO2008113255A1 Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof
09/25/2008WO2007146349A3 Cgrp receptor antagonists
09/25/2008US20080234344 Amino Acid and Peptide Conjugates of Arylalkylic Acids for Cosmetic Use
09/25/2008US20080234292 Such as S)-(1-(1-Aminobicyclo[2.2.2]oct-4-yl)aminoacetyl)-2-cyanopyrrolidine; inhibitors of the enzyme dipeptidyl peptidase; antidiabetic agents
09/25/2008US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk)
09/25/2008US20080233163 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease
09/25/2008CA2681124A1 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
09/25/2008CA2680592A1 Desferrithiocin polyether analogues and uses thereof in treating pathological conditions
09/24/2008EP1972621A1 Method for producing thiazole compound
09/24/2008EP1971602A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
09/24/2008EP1971584A2 Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins
09/24/2008CN101273048A Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
09/24/2008CN101273023A 5-substituted thiazol-2-yl amino compounds and compositions as protein kinase inhibitors
09/24/2008CN101273022A Thiazoles derivatives as AMPK activator
09/24/2008CN101273019A Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as C-Met inhibitors
09/24/2008CN101273015A 3-cyclyl-2- (4-sulfamo yl-phenyl) -N-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
09/24/2008CN101270099A Method for preparing N-[2-(1-ethoxycarbonyl-3-phenylpropylamino)-tauryl]-thiazolidinecarboxylic acid and its derivant
09/24/2008CN100420678C Cyclization process for substituted benzothiazole derivatives
09/24/2008CN100420677C Substituted aryl methylene sulfonylated aza cyclo-pentanone compounds, its medicine compositions and its preparing process and use
09/24/2008CN100420672C Selective COX-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 337